D.E. Shaw & Co’s Acutus Medical Inc AFIB Stock Holding History

D.E. Shaw & Co’s Portfolio AFIB Stock Details AFIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-11,765	Closed	-$13K	–	5631
2022 Q2	$13K	Buy	+11,765	New	+$10.1K	﹤0.01%	5098

Other funds holding AFIB

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

KSCM

Kamunting Street Capital Management Miami Beach, Florida $183M AUM 2.19% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co's AFIB Position: Q3 2022 in Review

D.E. Shaw & Co sold out of Acutus Medical Inc (AFIB) in Q3 2022, closing a stake of 11,765 shares — an estimated $13K sold.

D.E. Shaw & Co first reported a position in AFIB in Q2 2022 and held it in 1 quarter. The position peaked at $13K in Q2 2022. 37 funds tracked by Wall St. Rank hold AFIB as of Q3 2022.

D.E. Shaw & Co reported no remaining Acutus Medical Inc position as of Q3 2022 after selling out during the quarter.
D.E. Shaw & Co sold 11,765 Acutus Medical Inc shares in Q3 2022, an estimated $13K.
D.E. Shaw & Co first reported a position in Acutus Medical Inc in Q2 2022 and held it in 1 quarter.
D.E. Shaw & Co's Acutus Medical Inc position peaked at $13K in Q2 2022.
37 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.